Precision for Medicine

The FDA’s Project Optimus is doing more than adjusting dose tables—it’s reshaping dose selection philosophy. At Precision, we’re helping sponsors translate Optimus principles into actionable trial design, biomarker integration, and regulatory strategy. hubs.ly/Q04p0fQ60

China. Japan. Korea. Each market has its own regulatory requirements, its own access hurdles, its own standards of evidence. The Institute@Precision Asia-Pacific Series helps you navigate these challenges with confidence. Explore the series: hubs.ly/Q04nWdDQ0

James Cheong and PeiSzu Lee will be at BIO Asia-Taiwan to connect with you on the latest developments in oncology, rare disease, and autoimmune clinical trial design and execution. Reach out directly to schedule a meeting or stop by our exhibit in the Austrade pavilion.

Deliver your oncology therapy at scale with a CRO partner built to streamline development for personalized medicines. hubs.ly/Q04nBmSH0

We're working for a better tomorrow. Join us! Quality Assurance Specialist III (India) - hubs.ly/Q04nqxNy0 Senior Data Engineer (India) - grnh.se/cqi7x4zd4us Senior Clinical Data Associate (India) - hubs.ly/Q04nqnVQ0

Announcing the latest knowledge drop from the Institute@Precision: The Asia-Pacific Series hubs.ly/Q04n4rbt0 Each quarter, the Institute@Precision gathers expert perspectives that surround a hot issue in our industry. Join the conversation.

Jing Ping Yeo, VP, Clinical Operations & Head of Asia Pacific, will join the Oracle Health & Life Sciences Roundtable in Singapore as a featured speaker discussing the digital transformation of pharma, biotech & CRO organizations across Singapore & ASEAN.

Impact outcomes no matter where you work (remotely). Director, Project Mgmt - Autoimmune: hubs.ly/Q04mNd570 Sr Project Mgr – Oncology: hubs.ly/Q04mNmVt0 Bus Dev Director, Biospecimen: hubs.ly/Q04mNb_S0 Feasibility Mgr - Post Award: hubs.ly/Q04mNl0D0

Your Clinical Trial Manager carries the full arc of your program, including start‑up, activation, and data lock. Here we outline the 6 domains CTMs own, and why your next CTM choice may define your trial’s pace: hubs.ly/Q04mCHYF0

Meet the Precision team at BIO International Convention this week in San Diego. And don’t miss the panel “Unlocking the Uncommon: Accelerating Cell & Gene Therapies for Rare Diseases,” moderated by Nick on Tuesday, June 23 from 1:45–2:45 PM.

People are more than their diagnosis, and you are much more than your job title. Start Up Lead (Turkey) - hubs.ly/Q04l_PMt0 Manager, Site Start Up (APAC) - hubs.ly/Q04l_FyY0 Seniorr Feasibility Associate / Feasibility Manager (EU) - hubs.ly/Q04l_zws0

How operational discipline kept an early-phase autoimmune trial on track when the enrollment landscape shifted. If you are navigating early-phase autoimmune development and need a partner who knows these studies play by different rules, this is for you. hubs.ly/Q04lQS020

The devil really is in the detail when it comes to rare disease research. The patients are some of the most precious & vulnerable, meaning every sample, insight, analysis & submission must align. ​Explore Precision's Rarefied Thinking approach in detail: hubs.ly/Q04lK8GX0

Discover real‑world evidence emerging from 2025–26 clinical programs. Precision's Nicholas Richardson & his panel will discuss how adaptive trial strategies, single‑arm designs & alternative data sources are enabling robust evidence generation despite small patient populations.

We’re pleased to announce that Precision for Medicine is now a member of the Paris Saclay Cancer Cluster (PSCC). Combined with the renewal of our French CIR accreditation, it reinforces our position as a committed partner within the French life sciences landscape.

Proud to see our Frederick, MD team continue its support of Girls on the Run at this year’s “Celebrate Your Start” 5K, a partnership we’ve maintained since 2015. Our team, along with friends and family, enjoyed spending the morning together while celebrating personal milestones.

BriefGlance called it an FDA “Dream Team” for oncology trials. Precision for Medicine brings together 3 former FDA oncology leaders w/ deep experience across solid tumors, hematologic malignancies, biomarker strategy, novel endpoints & complex trial design hubs.ly/Q04kJwJq0

The Precision team will be onsite at the European Hematology Association Congress (EHA) this week to discuss how we are advancing clinical development and delivering smarter, more efficient solutions across hematology.

Seeking a Business Development Director (West Coast, US) eager to reach new heights and advance the development of life-changing treatments. hubs.ly/Q04kh_2z0

Patients with the same diagnosis can have different underlying biology, progression patterns & treatment responses. Traditional trial designs average that complexity out. If you get early assumptions wrong, every downstream decision gets harder. hubs.ly/Q04k1XdJ0